Organon & Co | OGN - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celltrion KRW 78.68B 25.51B 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Gilead Sciences USD 645M 70M 2026-03
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Merck USD 3.86B 541M 2026-03
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Novartis USD 4.46B 99M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Organon & Co USD 983M 31M 2026-03
Ovoca Bio EUR 186K 23K 2025-06
Pharma Mar EUR 43.83M 10.51M 2026-03
Qiagen NV USD 72.66M 2.11M 2025-12
Sartorius EUR 345.3M 2.2M 2026-03
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 346.6M 102.71M 2025-12